February 22, 2012
By Norma Erickson, President of SANEVAX, INC.
On January 1, 2011, Dr. Philip Castle became the first Executive Director of the American Society of Clinical Pathology (ASCP) Institute. Dr. Philip E. Castle also served on a data safety and monitoring board for human papillomavirus vaccines for Merck and is well known for his proposals directing publicly financed programs or insurers to pay for vaccination of HPV-naive girls (ages 11-12) as a comprehensive strategy for cervical cancer prevention.
Now he is also known for accusing physicians of abusing HPV DNA testing in fairly large numbers.
But one gynecologist is firing back as Dr. Castle does not even have a license to practice medicine and has never handled a clinical problem facing a patient. Read her article herehttp://gynogab.blogspot.com.
It is incomprehensible to not test the HPV infections after mass vaccination of young girls. Is HPV DNA testing the way to find out if the vaccine really works?
How can a pathologist like Dr. Castle direct the activities of the American Society for Clinical Pathology Institute?
Are American clinical pathologists interested in medical science? Or are they only concerned with promoting HPV vaccines with publicly funded programs?
1.Castle PE, Zhao FH. Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs. J Infect Dis 2011; 204: 335-7.http://jid.oxfordjournals.org/content/204/3/335.full.pdf+html
2.Castle PE. Abuses in human papillomavirus DNA testing. Obstet Gynecol 2011;118:1-3.http://www.ncbi.nlm.nih.gov/pubmed/21691156